These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22928481)

  • 1. Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone.
    van Oosterwijk JG; de Jong D; van Ruler MA; Hogendoorn PC; Dijkstra PD; van Rijswijk CS; Machado I; Llombart-Bosch A; Szuhai K; Bovée JV
    BMC Cancer; 2012 Aug; 12():375. PubMed ID: 22928481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Profiling Identifies Association of
    Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
    Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.
    Monderer D; Luseau A; Bellec A; David E; Ponsolle S; Saiagh S; Bercegeay S; Piloquet P; Denis MG; Lodé L; Rédini F; Biger M; Heymann D; Heymann MF; Le Bot R; Gouin F; Blanchard F
    Lab Invest; 2013 Oct; 93(10):1100-14. PubMed ID: 23958880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
    Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
    Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production.
    Calabuig-Fariñas S; Benso RG; Szuhai K; Machado I; López-Guerrero JA; de Jong D; Peydró A; San Miguel T; Navarro L; Pellín A; Llombart-Bosch A
    Pathol Oncol Res; 2012 Oct; 18(4):793-802. PubMed ID: 22350793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
    Denu RA; Yang RK; Lazar AJ; Patel SS; Lewis VO; Roszik J; Livingston JA; Wang WL; Shaw KR; Ratan R; Zarzour MA; Bird J; Raza S; Akdemir KC; Rodon Ahnert J; Subbiah V; Patel S; Conley AP
    Clin Cancer Res; 2023 Dec; 29(23):4844-4852. PubMed ID: 37747813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct IDH1/2-associated Methylation Profile and Enrichment of
    Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
    Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis.
    Lam SW; van Langevelde K; Suurmeijer AJH; Cleven AHG; Bovée JVMG
    Histopathology; 2019 Dec; 75(6):843-852. PubMed ID: 31297850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?
    Knösel T; Werner M; Jung A; Kirchner T; Dürr HR
    Pathol Res Pract; 2014 Mar; 210(3):194-7. PubMed ID: 24405942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
    Lucas CG; Grenert JP; Horvai A
    Arch Pathol Lab Med; 2021 Aug; 145(8):1009-1017. PubMed ID: 33147331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
    Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
    Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
    Oyama R; Kito F; Takahashi M; Sakumoto M; Shiozawa K; Qiao Z; Noguchi R; Kubo T; Toki S; Nakatani F; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2019 Apr; 32(2):202-213. PubMed ID: 30737713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma.
    Meijer D; de Jong D; Pansuriya TC; van den Akker BE; Picci P; Szuhai K; Bovée JV
    Genes Chromosomes Cancer; 2012 Oct; 51(10):899-909. PubMed ID: 22674453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH1 Mutation Induces HIF-1
    Hu X; Li L; Eid JE; Liu C; Yu J; Yue J; Trent JC
    Dis Markers; 2022; 2022():7729968. PubMed ID: 35198082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome.
    Morrison C; Radmacher M; Mohammed N; Suster D; Auer H; Jones S; Riggenbach J; Kelbick N; Bos G; Mayerson J
    J Clin Oncol; 2005 Dec; 23(36):9369-76. PubMed ID: 16361637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDH mutation status in a series of 88 head and neck chondrosarcomas: different profile between tumors of the skull base and tumors involving the facial skeleton and the laryngotracheal tract.
    Tallegas M; Miquelestorena-Standley É; Labit-Bouvier C; Badoual C; Francois A; Gomez-Brouchet A; Aubert S; Collin C; Tallet A; de Pinieux G
    Hum Pathol; 2019 Feb; 84():183-191. PubMed ID: 30296521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.
    Bovée JV; Cleton-Jansen AM; Rosenberg C; Taminiau AH; Cornelisse CJ; Hogendoorn PC
    J Pathol; 1999 Dec; 189(4):454-62. PubMed ID: 10629543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas.
    Amary MF; Ye H; Forbes G; Damato S; Maggiani F; Pollock R; Tirabosco R; Flanagan AM
    Virchows Arch; 2015 Feb; 466(2):217-22. PubMed ID: 25432631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
    Joseph NM; McGill KC; Horvai AE
    Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.